Publications

Latest publication 09/19/2014

RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardio

Recent findings indicate that apolipoprotein A-I (ApoA-I) may be a protective humoral mediator involved in remote ischemic preconditioning (RIPC)....

Array
(
    [id_prestablog_news] => 711
    [id_shop] => 1
    [date] => 2014-09-19 00:00:00
    [date_modification] => 2024-02-09 14:15:12
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [ishero] => 0
    [prim_key] => 1391
    [id_lang] => 1
    [title] => RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardio
    [paragraph] => RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotection.
    [content] => 
Authors
Kalakech H, Hibert P, Prunier-Mirebeau D, Tamareille S, Letournel F, Macchi L, Pinet F, Furber A, Prunier F



 Lab
l'uNAM Université, Angers, France; Université d'Angers, Laboratoire Cardioprotection, Remodelage et Thrombose, Angers, France.


Journal
PLoS One.


Abstract
Recent findings indicate that apolipoprotein A-I (ApoA-I) may be a protective humoral mediator involved in remote ischemic preconditioning (RIPC). This study sought to determine if ApoA-I mediates its protective effects via the RISK and SAFE signaling pathways implicated in RIPC. Wistar rats were allocated to one of the following groups.

CONTROL:
rats were subjected to myocardial ischemia/reperfusion (I/R) without any further intervention; RIPC: four cycles of limb I/R were applied prior to myocardial ischemia; ApoA-I: 10 mg/Kg of ApoA-I were intravenously injected prior to myocardial ischemia; ApoA-I + inhibitor: pharmacological inhibitors of RISK/SAFE pro-survival kinase (Akt, ERK1/2 and STAT-3) were administered prior to ApoA-I injection. Infarct size was significantly reduced in the RIPC group compared to CONTROL. Similarly, ApoA-I injection efficiently protected the heart, recapitulating RIPC-induced cardioprotection. The ApoA-I protective effect was associated with Akt and GSK-3? phosphorylation and substantially inhibited by pretreatment with Akt and ERK1/2 inhibitors. Pretreatment with ApoA-I in a rat model of I/R recapitulates RIPC-induced cardioprotection and shares some similar molecular mechanisms with those of RIPC-involved protection of the heart.


Keywords/Topics
Miscellaneous research domains
    [meta_description] => 
    [meta_keywords] => http://www.ncbi.nlm.nih.gov/pubmed/25237809
    [meta_title] => 
    [link_rewrite] => risk-and-safe-signaling-pathway-involvement-in-apolipoprotein-a-i-induced-cardioprotection-
    [actif_langue] => 1
    [read] => 850
    [count_comments] => 0
    [id] => 711
    [categories] => Array
        (
            [26] => Array
                (
                    [id_prestablog_categorie] => 26
                    [title] => Miscellaneous research domains
                    [link_rewrite] => Miscellaneous-research-domains
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

        )

    [authors] => 
    [paragraph_crop] => RISK and SAFE signaling pathway involvement in apolipoprotein A-I-induced cardioprotection.
    [link_for_unique] => 1
)
1
Read more

Filters

Clear all

Categories

View all products

Applications

Dates

<< 1 ... 140 141 142 143 144 >>